Dave Fornell, ITN Editor
Dave Fornell, ITN Editor

Dave Fornell is the editor of ITN and DAIC magazines

Blog | Dave Fornell, ITN Editor | HIMSS | March 24, 2016

New Trends and Technology at HIMSS 2016

The need for improved efficiency in healthcare and the new requirements of U.S. healthcare reform have rapidly made the Healthcare Information and Management Systems Society (HIMSS) annual meeting into one of the largest medical conferences in the world. More than 1,300 companies exhibited on the expo floor, covering IT for every medical specialty including cardiology, radiology and radiation oncology. 

The major themes this year included how to leverage technology to implement population health initiatives, analytics software, patient engagement, improve connectivity and data/image sharing between disparate IT systems and outside physicians, and how to improve workflow efficiency. 

Analytics software and population health appeared to be the poster children topics of HIMSS 2016. With all of healthcare now migrating to electronic medical record platforms, this data can be mined for business uses such as better management of inventory, procedural room use, imaging utilization, staff performance, radiation dose management, monitoring factors for patient satisfaction and to help identify bottlenecks in patient discharge, door-to-balloon times, STAT radiology reads and what contributes to poor or improved patient outcomes. This data has been available for years at many facilities, but it is the new level of analytics software integration that now makes data mining possible for all these things on one screen using one program. 

Examples of analytics software and how technology can improve workflow on PACS and cardiovascular information systems can be found in the video “What to Look for in PACS Workflow Efficiency.”

However, technology is now much more sophisticated than simply pulling data on what has already happened, and can now help predict what will happen. This is the premise of the new IT arena of population health management. If all the risk factors are known for poor clinical outcomes or that lead to re-admissions, these can be tracked using software for all patients to determine who should be allocated additional, scarce resources. This is especially true for high-cost, high-readmission conditions such as heart failure, COPD and diabetes, or high-volume emergency department (ED) patient presentations, such as chest pain. Population health software starts with pulling the patient’s history, current drugs, diagnoses codes and procedures from the electronic medical record. But, it goes beyond this data to pull relevant information such as socio-economic and environmental considerations based on a patient’s address, access to healthcare based on proximity to clinics or hospitals, how often their prescriptions are filled to determine medication compliance, weather conditions, previous lab results, imaging and procedural reports, and many other factors. The software compares these statistics to local, regional and national averages to determine if a patient is at a higher risk than others for everything from readmissions, bed sores and infection, or to triage which chest pain patients in a busy ED are the most likely to be suffering coronary ischemia rather than gastrointestinal distress.

Some software vendors are taking this model to the next level of predictive analytics using health system-wide data or regional health data exchanges to mine thousands of data points to determine which patients in a county or region would be ideal candidates for pre-emptive care. This includes identifying who might be qualified for CT lung cancer screenings, or who should receive calls from healthcare outreach programs to prevent everything from low-birth weight babies in low-income areas and identifying heart failure patients before they ever present with acute symptoms in an ED.

Watch a video of how the University of Mississippi is using population health to identify high-risk cardiac patients.

Patient engagement has become a major topic of discussion as providers try to figure out how to leverage IT to meet this Stage 3 Meaningful Use requirement. I spoke with third-party health IT experts and visited vendors on the HIMSS expo floor for demonstrations of their technology, which can be viewed in the video “Patient Engagement Technology for Imaging.”

Another Stage 3 requirement is the use of clinical decision support (CDS) software to help reduce the number of unnecessary or inappropriate exams. I received feedback from consultants and had examples of this technology demonstrated by vendors in the video “Examples of Clinical Decision Support for Cardiology and Radiology.”

Related Content

For years telehealth has danced at the edges of healthcare
Feature | Teleradiology | January 21, 2021 | By Jef Williams
All indications point to 2021 being the year of the return path of this boomerang event that sent us all in a differe
Steinberg Diagnostic Medical Imaging headquarters.

Steinberg Diagnostic Medical Imaging headquarters.

Sponsored Content | Case Study | Contrast Media Injectors | January 21, 2021
Steinberg Diagnostic Medical Imaging (SDMI) was founded 30 years a
The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
Radiologists have recently taken on the role of activists and are tackling pressing issues in healthcare, including breast density

Getty Images

Feature | Women's Health | January 20, 2021 | By Fazila Seker, Ph.D.
Radiologists — who have long been professionals in the metaphorical and literal back-rooms of healthcare — have recen
MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.

MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI. Image courtesy of Exact Imaging

Feature | Prostate Cancer | January 20, 2021 | By Brian Wodlinger, Ph.D.
Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next
An interview with Eric Liederman, M.D., MPH, Director of Medical Informatics for The Permanente Medical Group, in Kaiser Permanente’s Northern California Region, on the explosion of telemedicine in the COVID-19 era

Getty Images

Feature | Radiology Business | January 20, 2021 | By Melinda Taschetta-Millane
Vendor neutral archives enable a single, central location to store large volumes of radiology data, but now need to be able to house data from dozens of other departments with a wide array of data formats. This article originally ran as an introduction to the Vendor Neutral Archives comparison chart.
Feature | Vendor Neutral Archive (VNA) | January 20, 2021 | By Dave Fornell
Most radiologists and clinicians are not trained as...
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
According to a new...
Previously approved by FDA in the USA, MyLab X8 expands the reach of the MyLab Ultrasound Product Line with a fully featured premium imaging solution, integrating the latest technologies and delivering superior image quality without compromising workflow or efficiency.
News | Ultrasound Imaging | January 20, 2021
January 20, 2021 — Esaote North America announces that the...